Carregant...
In Reply
This letter to the editor responds to Badoui et al. regarding data on abemaciclib dosages and adverse events.
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265353/ https://ncbi.nlm.nih.gov/pubmed/33826783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13782 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|